Fact-checked by Grok 2 weeks ago

20-Hydroxyecdysone

20-Hydroxyecdysone, also known as ecdysterone, is a naturally occurring hormone characterized by its polyhydroxylated ketosteroid structure and the molecular formula C₂₇H₄₄O₇. It serves as the principal molting hormone in arthropods, regulating critical developmental processes such as , , and by binding to receptors and modulating . In plants, where it occurs as a , it functions primarily as a mechanism against herbivorous and pathogens, deterring feeding and inducing metabolic disruptions in non-adapted consumers. Chemically, 20-hydroxyecdysone features a cyclopentanoperhydrophenanthrene with a cis A/B ring junction, a 7-en-6-one , and multiple hydroxyl groups, including one at the 20-position that distinguishes it from its precursor, . First isolated from the silk moth in the 1960s, it is biosynthesized from via the in both arthropods and plants, with over 400 related ecdysteroids identified to date. In arthropods, its levels fluctuate in precise pulses—typically in the nanomolar to micromolar range—to orchestrate stage-specific transitions, such as from to , through pathways involving early and late responses. Beyond its ecological roles, 20-hydroxyecdysone has garnered attention for potential therapeutic applications in mammals, where it exhibits anabolic effects by enhancing protein synthesis and muscle growth without androgenic or estrogenic activity, activating pathways like PI3K/AKT/. Studies suggest benefits in treating neuromuscular disorders like and , as well as cardio-metabolic conditions including and , with ongoing clinical trials evaluating its efficacy. Additionally, it demonstrates , , and antineoplastic properties, positioning it as a candidate for respiratory diseases and stress-related ailments, though safety and optimal dosing require further validation. Commercially, it is extracted from high-yielding plant sources such as Cyanotis arachnoidea and , which can contain up to 5% dry weight.

Chemical properties

Structure and nomenclature

20-Hydroxyecdysone is a polyhydroxylated ecdysteroid with the molecular formula C_{27}H_{44}O_7 and a molecular weight of 480.65 g/mol. Its structure consists of a tetracyclic steroid backbone derived from cholesterol, featuring rings A, B, C, and D fused in a cholestane configuration, with a ketone functional group at carbon 6 and a double bond between carbons 7 and 8 in ring B. Hydroxyl groups are attached at positions 2 (β), 3 (β), 14 (α), 20 (R), 22 (R), and 25, contributing to its polarity and solubility characteristics. The molecule exhibits specific stereochemistry at its chiral centers, defined as (2β,3β,5β,14α,20R,22R). The systematic IUPAC name for 20-hydroxyecdysone is (2β,3β,5β,14α,20R,22R)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one. It is commonly referred to by synonyms such as ecdysterone, β-ecdysone, or simply 20E in . In comparison to the related ecdysone, 20-hydroxyecdysone includes an additional hydroxyl group at position 20 on the , resulting in one more oxygen atom and distinguishing its structural profile.

Physical and chemical characteristics

20-Hydroxyecdysone appears as a white to off-white crystalline powder. It exhibits moderate in (approximately 10 mg/mL), but is readily soluble in organic solvents such as (around 25 mg/mL), DMSO (around 30 mg/mL), and DMF (around 30 mg/mL). The compound's multiple hydroxyl groups contribute to its values, with the strongest acidic approximately 13.3. 20-Hydroxyecdysone is stable when stored dry in the dark at room temperature for extended periods (at least 4 years), but it is sensitive to light, heat, and strong acids or bases. Optimal storage conditions involve -20°C in an inert atmosphere to maintain integrity. Key spectroscopic properties include a UV absorption maximum at 243 nm, attributable to the 14α-hydroxy-7-en-6-one chromophore in the B-ring. In mass spectrometry, it shows a characteristic protonated molecular ion at m/z 481 [M+H]⁺. NMR spectra confirm the structure, with detailed ¹H and ¹³C assignments available from reference standards. Isolation from natural sources typically involves basic extraction techniques, such as refluxing plant material in ethanol, followed by purification using macroporous resins and recrystallization to achieve high purity (>97%).

Biosynthesis and natural occurrence

Biosynthesis in arthropods

20-Hydroxyecdysone (20E) biosynthesis in arthropods begins with dietary as the obligate precursor, which is absorbed and transported to specialized endocrine glands. Arthropods lack the ability to synthesize sterols , relying instead on exogenous sources for . The initial conversion of to 7-dehydrocholesterol is catalyzed by the Rieske-domain oxygenase (Nvd), a rate-limiting step that introduces a at the C7-C8 position. Subsequent modifications involve a series of hydroxylations mediated by enzymes encoded by the Halloween genes, transforming through intermediates such as 5β-cholane-3α,7α-diol and others into , the immediate precursor to 20E. These enzymes include (CYP307A1) for early oxidation steps, (CYP306A1) for 25-hydroxylation, Disembodied (CYP302A1) for 22-hydroxylation, and (CYP315A1) for 2β-hydroxylation, culminating in the final 20α-hydroxylation of to 20E by (CYP314A1). This multi-step pathway ensures the production of the active molting hormone, with variations in enzyme orthologs observed across lineages, such as in crustaceans where some CYP genes may be compensated by paralogs. In , 20E is primarily synthesized in the prothoracic glands, while in crustaceans, the Y-organs serve as the main site of production; synthesis occurs in pulses aligned with molting cycles, peaking during premolt stages to trigger renewal. is tightly regulated by neuropeptides: in , prothoracicotropic hormone (PTTH) from the stimulates the prothoracic glands via cyclic AMP signaling to initiate release, while through the ecdysone receptor (EcR) in PTTH neurons modulates timing. In crustaceans, molt-inhibiting hormone (MIH) from the eyestalk sinus gland suppresses Y-organ activity, with de-repression driving synthesis peaks. Genetic studies provide strong evidence for these pathways, as mutations or RNAi knockdown of or Halloween genes result in developmental arrest due to ecdysteroid deficiency, phenotypes rescuable by exogenous 20E or precursors like . For instance, shade mutants fail to produce 20E, halting , underscoring the essential role of these enzymes in arthropod post-embryonic development.

Sources in plants and other organisms

20-Hydroxyecdysone, a prominent , occurs naturally in numerous , particularly within families such as and . In , genera like exhibit high accumulation, with levels reaching 1–2% of dry weight in some . members, including Achyranthes such as A. faurieri and A. bidentata, also contain significant amounts, often up to 1.74% dry weight in roots. Spinacia oleracea (), another representative, shows variable concentrations, typically ranging from 0.52 to 428 µg/g dry weight, though totals for ecdysteroids in can approach 3% under optimal conditions. Additionally, Cyanotis like C. arachnoidea are notable sources, with roots accumulating up to 5.5% dry weight. These phytoecdysteroids serve as defensive compounds in , deterring herbivorous by disrupting their molting and feeding behaviors, thereby reducing phytophagous damage. Concentrations of 20-hydroxyecdysone vary markedly across plant organs and are influenced by environmental factors. Highest levels are often found in roots and seeds, as seen in Achyranthes japonica, where root and floral parts exceed stem and leaf concentrations during reproductive stages, and in Chenopodium album, with peaks in anthers, young leaves, and seeds. Stress conditions, such as salinity, induce accumulation; for instance, in Spinacia oleracea shoot cultures, 20-hydroxyecdysone reaches 0.20 mg/g dry weight at 200 mM NaCl, aiding membrane protection. Other stressors like jasmonates, physical damage, temperature fluctuations, and seasonal changes further modulate levels, with higher yields in spring shoots and autumn roots of perennials. Over 500 phytoecdysteroid analogues have been identified across more than 100 plant families, reflecting diverse accumulation patterns. Beyond , 20-hydroxyecdysone appears in trace amounts in other organisms, often linked to dietary exposure or environmental transfer. Limited reports indicate presence in , fungi, and ferns, though at low levels compared to angiosperms. In , biotransformations occur but natural endogenous production is not well-documented. Vertebrates acquire traces primarily through plant-based diets, as evidenced by detection in following ingestion of ecdysteroid-rich foods. Commercially, 20-hydroxyecdysone is extracted from high-yield sources like (aerial parts) and Leuzea carthamoides (syn. , roots at 1–2% dry weight), used in supplements and pharmacological preparations. Evolutionarily, phytoecdysteroids are proposed as ancient defense mechanisms, originating in ferns around the period (approximately 400 million years ago), predating diversification and functioning as antifeedants or endocrine disruptors against early herbivores. Analytical detection of 20-hydroxyecdysone in plant extracts relies on coupled with (HPLC-MS/MS), enabling sensitive quantification of low levels (limits of detection 6–80 ng/g). This method involves solid-liquid extraction with methanol-ethanol-water mixtures followed by cleanup, achieving recoveries of 75–99% and precision below 9% relative standard deviation. It simultaneously identifies multiple ecdysteroids, such as 20-hydroxyecdysone alongside makisterone A, supporting ecological and pharmaceutical .

Biological functions

Role in arthropod development

20-Hydroxyecdysone (20E) functions as the principal regulating molting and in , triggering by activating a complex composed of the ecdysone receptor (EcR) and (RXR, known as ultraspiracle or USP in ). This heterodimer binds to DNA response elements, initiating a transcriptional cascade that includes early genes such as Broad-Complex (BR-C), E74, E75, and E93, which coordinate downstream expression of genes for remodeling, synthesis, and physiological adaptations. The pathway induces production of enzymes like proteases and chitinases essential for degrading the old exoskeleton during apolysis and facilitating new formation. In , 20E precisely times developmental transitions, such as the larval-to-pupal , where rising s promote the histolysis of larval organs and of imaginal discs into structures. fluctuations are critical: low levels during inter-molt periods support growth and maintenance, while periodic high pulses—often 7-fold elevations—signal commitment to molting, culminating in behaviors mediated by neuropeptides like ecdysis-triggering hormone (). In crustaceans, 20E coordinates by elevating levels that parallel ovarian maturation and protein synthesis, with ovaries sequestering these hormones for provisioning. Across chelicerates, including ticks and scorpions, 20E supports analogous molting cycles and reproduction, though species like mites may prioritize ponasterone A as the dominant . Experimental manipulations confirm 20E's mechanistic role; injections into insect larvae, such as , induce dose-dependent molting and pupation by mimicking natural titer peaks. Conversely, RNAi-mediated knockdown of EcR in or Blattella germanica arrests development at molting stages, resulting in incomplete and lethality due to failed cuticle separation. These findings underscore 20E's conserved function in synchronizing post-embryonic development across diverse taxa.

Functions in plants and other non-arthropods

In , 20-hydroxyecdysone functions primarily as a , serving as a mechanism against herbivorous by acting as a feeding deterrent. When ingested by non-adapted , it mimics the arthropod molting hormone, leading to premature or disrupted molting, reduced feeding, and impaired and . For instance, exogenous application of 20-hydroxyecdysone to host significantly decreases larval feeding and survival in species like the (Plutella xylostella). This deterrent effect is concentration-dependent, with higher levels causing stronger avoidance behaviors in and other herbivores. Additionally, phytoecdysteroids exhibit allelochemical activity that enhances plant tolerance to pests such as nematodes, potentially inhibiting their growth and through similar hormonal interference. Unlike in arthropods, 20-hydroxyecdysone lacks endogenous hormonal activity or receptor-mediated signaling in , indicating its role is strictly defensive rather than regulatory for . Experimental bioassays have demonstrated reduced insect feeding and herbivory on enriched with high levels of 20-hydroxyecdysone, such as (Spinacia oleracea), where inducible production following damage further amplifies this protection. Phytoecdysteroids like 20-hydroxyecdysone are thought to have evolved as part of a adaptation, allowing to exploit the hormonal vulnerabilities of herbivores for ecological advantage. In non- invertebrates, such as nematodes and annelids, 20-hydroxyecdysone plays limited physiological roles, often related to exogenous rather than endogenous . In plant-parasitic nematodes, dietary uptake from host disrupts molting and development, serving as a novel defense mechanism without evidence of an intrinsic regulatory function in the nematodes themselves. For annelids, 20-hydroxyecdysone acts as an active molting hormone that supports growth and regenerative processes, with confirmed C-20 similar to arthropod pathways. Trace amounts of 20-hydroxyecdysone can transfer through dietary sources to vertebrates, but no clear endogenous function has been established in these organisms. Beyond defense, 20-hydroxyecdysone may contribute to responses in certain , particularly as an in heavy metal-exposed seedlings, where it enhances ascorbate-glutathione cycle activity and protects against oxidative damage. In or stress-adapted , it potentially serves as an , aiding tolerance to abiotic stresses like or by stabilizing cellular functions, though this role remains secondary to its anti-herbivore effects.

Effects in mammals

Mechanisms of action

In mammals, 20-hydroxyecdysone (20E) does not bind to the ecdysone receptor (EcR), which is absent in mammalian cells, distinguishing its actions from those in arthropods where EcR drives developmental signaling. Instead, 20E exerts effects through interactions with mammalian receptors, including activation of estrogen receptor beta (ERβ) and the Mas1 receptor, a (GPCR) belonging to the Mas-related G protein-coupled receptor (Mrgpr) family. ERβ involvement is evidenced by 20E-induced of reporter genes in ERβ-transfected HEK293 cells and prevention of myotube by ERβ-selective antagonists in cells, although direct binding to ERβ has not been conclusively demonstrated. Mas1 activation occurs via 20E stimulation of -(1-7) production, promoting and anabolic signaling. Additionally, 20E engages the PI3K/Akt/ pathway, enhancing protein synthesis in cells as shown by increased in myotubes at concentrations around 1 μM. Genomic effects of 20E primarily occur through ERβ-mediated transcription, leading to upregulation of insulin-like growth factor 1 (IGF-1) expression and inhibition of myostatin, a negative regulator of muscle growth; for instance, 20E treatment elevates serum IGF-1 levels in male rats and reduces myostatin mRNA in C2C12 cells in a dose-dependent manner (0.001–10 μM). Mas1 activation further contributes to myostatin suppression via the renin-angiotensin-aldosterone system (RAAS) protective arm. These transcriptional changes support anabolic processes in muscle tissue. Non-genomic effects involve rapid signaling cascades, including elevation of intracellular calcium levels in cells, which precedes Akt and increased protein within minutes of 20E exposure. 20E also activates (AMPK) in mammalian liver and , promoting metabolic shifts such as reduced through increased AMPK . These membrane-initiated responses occur independently of nuclear receptors and highlight 20E's role in quick cellular adaptations. The response to 20E exhibits dose dependency, with low micromolar concentrations (e.g., 0.01–1 μM) promoting anabolic effects like protein synthesis, while higher doses may shift toward metabolic regulation; in vitro studies show biphasic glucose secretion responses in hepatocytes, peaking at intermediate doses. Recent investigations confirm 20E's activation of the RAAS protective arm via Mas1, yielding anti-fibrotic and anti-inflammatory outcomes in endothelial and muscle cells, as demonstrated in models of metabolic stress.

Physiological effects

20-Hydroxyecdysone exhibits metabolic effects in mammals, including enhanced protein synthesis and production. In cells, it stimulates protein synthesis through activation of the PI3K/Akt pathway, leading to increased myotube without androgenic activity. It also promotes production by phosphorylating AMPK and , which supports mitochondrial function and reduces . Furthermore, 20-hydroxyecdysone boosts by lowering plasma triglycerides and levels while improving insulin sensitivity; in diet-induced obese mice, (10 mg/kg for 13 weeks) reduced body by 18%, adipose mass by 41%, and plasma insulin by 4.5-fold, alongside decreased expression of gluconeogenic enzymes like PEPCK. In terms of tissue-specific responses, 20-hydroxyecdysone promotes hypertrophy by increasing fiber cross-sectional area in a muscle-type-specific manner; in rats, (5 mg/kg for 5 days) enlarged slow-twitch soleus fibers by up to 20% and fast-twitch fibers in the extensor digitorum longus by 15%, accompanied by elevated myonuclear numbers indicative of satellite cell activation. It provides through anti-apoptotic and mechanisms, as demonstrated in models of where it preserved neuronal viability against . Additionally, it exerts effects, including a 38% reduction in in overweight patients with treated with 100 mg/day for 3 months. In high-fat-high-fructose-fed ovariectomized rats, 20E (10-20 mg/kg) improved metabolic and cardiovascular function via activation of AMPK (up to +262%) and increased FGF21 expression (up to +468%). The toxicity profile of 20-hydroxyecdysone is favorable, with low acute toxicity reported; the oral LD50 exceeds 9 g/kg in mice, and intraperitoneal LD50 is 6.4 g/kg in rodents, while no subacute toxicity occurs in rats at chronic doses up to 2 g/kg/day. At high doses, it may exhibit potential estrogenic effects, as muscle hypertrophy induced by 20-hydroxyecdysone is reversible by estrogen receptor antagonists, suggesting mediation via ERβ. Animal studies highlight functional improvements, including increased in ; in young rats treated orally with 20-hydroxyecdysone (5 mg/kg for 28 days), grip strength rose by 18% compared to controls. It also aids in models, accelerating torque restoration in eccentric contraction-injured mouse muscles by 7 days post-injury at 50 mg/kg, with reduced histological damage markers. Research as of emphasizes 20-hydroxyecdysone's role in coupling and to enhance biosynthetic capacity, acting as a mimetic that activates AMPK to balance nutrient sensing and promote longevity-like effects in mammalian models. It also shows respiratory benefits, as demonstrated in a phase 2/3 trial (COVA) where oral BIO101 (20E, 200 mg twice daily) reduced the risk of death or by 43.8% in adults with severe (n=218).

Human applications

Use as a research tool

20-Hydroxyecdysone (20E), identified in the through bioassays on pupae and extracts from arthropods like the Jasus lalandii, has been instrumental in elucidating endocrinology, particularly the hormonal control of molting and . Early isolation efforts, building on the 1954 discovery of by Butenandt and Karlson, confirmed 20E as the principal active molting hormone via its ability to induce developmental transitions in ligated preparations, such as the blowfly Calliphora erythrocephala. This historical application in assays paved the way for its widespread use as a to decode signaling pathways. In research, 20E serves as a key inducer for studying molting and developmental processes in cell cultures and mutant models. For instance, supplementation with 20E triggers differentiation and molting hormone responses in insect cell lines like Sf9 from Spodoptera frugiperda, allowing researchers to dissect cellular mechanisms of without whole-organism variability. In genetic studies, injection or feeding of 20E rescues developmental arrest in ecdysone-deficient mutants of , such as l(3)dt, enabling analysis of EcR (ecdysone receptor) signaling cascades and downstream changes during . These applications have been crucial for mapping the hierarchical regulation of molting genes, including the identification of pulse-dependent activation of early puff genes in polytene chromosomes. In mammalian studies, 20E acts as a probe for investigating non-androgenic anabolic pathways, particularly through interactions with estrogen receptor beta (ERβ) and the . Binding assays and hypertrophy models in cells demonstrate that 20E activates ERβ to promote protein synthesis and muscle growth without agonism, serving as a model for selective anabolic agents. Similarly, administration in rats reveals 20E's modulation of signaling in liver and muscle, influencing metabolic adaptations like enhanced , which aids in studying insulin-independent anabolic effects. Methodologically, radiolabeled 20E, such as tritiated forms, facilitates receptor assays to quantify and specificity in EcR complexes from tissues, providing quantitative insights into ligand-receptor dynamics. Advanced tools like CRISPR-Cas9 screening target ecdysone pathway components, such as in , to identify novel regulators of 20E and validate pathway interactions genome-wide. However, limitations include species-specific responses, where 20E varies across taxa due to receptor isoform differences, and the need for high-purity preparations to prevent confounding effects from contaminants or analogs in experimental setups.

As a dietary supplement

20-Hydroxyecdysone, commonly marketed as ecdysterone, is available over-the-counter as a derived from plant extracts such as (Spinacia oleracea) or Cyanotis arachnoidea, typically in capsule or powder form with doses ranging from 50 to 200 mg per serving. These products are promoted primarily in the sports nutrition sector for enhancing muscle building, recovery, and athletic performance without the androgenic side effects associated with anabolic steroids. Supplements claim anabolic benefits through non-hormonal mechanisms, such as promoting protein synthesis and , positioning ecdysterone as a safer alternative to synthetic steroids. Due to emerging evidence of performance-enhancing potential, the (WADA) added ecdysterone to its Monitoring Program in 2020 to track prevalence and assess risks in competitive sports. Human evidence for efficacy remains mixed. A 2019 randomized controlled trial involving 46 resistance-trained men found that 200 mg/day of ecdysterone for 10 weeks significantly increased muscle mass and strength compared to , with no detected liver or toxicity. However, an earlier 2006 study on 45 resistance-trained males reported no significant improvements in or performance with ecdysterone supplementation. In the United States, ecdysterone is legally sold as a under the Dietary Supplement Health and Education Act (DSHEA), though it lacks FDA approval for specific health claims; in the , it is permitted in food supplements without authorization requirements for traditional botanical sources. Safety profiles indicate general tolerability, with a Phase 1 trial in 2023 showing no serious adverse events at doses up to 450 mg twice daily (900 mg/day) in healthy adults. Nonetheless, potential interactions with receptors raise concerns for hormonal , particularly in women or those with endocrine conditions. By 2024-2025, ecdysterone supplements have surged in popularity within , driven by WADA scrutiny and endorsements. Quality control challenges persist, including counterfeiting in plant-based extracts and variability in content, underscoring the need for third-party testing.

Potential in drug development

20-Hydroxyecdysone (20E) has emerged as a promising candidate in pharmaceutical research due to its anabolic and protective effects in mammals, particularly through activation of the Mas receptor in the renin-angiotensin-aldosterone system (RAAS). Preclinical studies have demonstrated its potential to enhance muscle protein synthesis and metabolic regulation without androgenic side effects, positioning it for development as an investigational drug under the name BIO101 by Biophytis. In neuromuscular disorders, 20E shows therapeutic promise, notably in Duchenne muscular dystrophy (DMD), where it activates the mechanistic target of rapamycin complex 1 (mTORC1) pathway to promote skeletal muscle hypertrophy and function. A 2025 preclinical study in DMD mouse models combined 20E with antisense oligonucleotide therapy targeting exon 23 of the Dmd gene, resulting in reduced dystrophic pathology, improved muscle force, and enhanced respiratory parameters. For cardio-metabolic conditions, 20E improves insulin sensitivity and glucose homeostasis; in ovariectomized rats on a high-fat-high-fructose diet, oral administration at 10 mg/kg/day for 4 weeks increased insulin receptor expression and reduced hyperglycemia and dyslipidemia. In respiratory diseases such as chronic obstructive pulmonary disease (COPD), 20E's activation of the protective RAAS arm may mitigate inflammation and muscle wasting, with preclinical evidence supporting its role in preserving respiratory muscle function in DMD models that overlap with COPD pathophysiology. Clinical trials have advanced 20E toward therapeutic use, with Phase I studies confirming and in healthy volunteers at doses up to 1400 mg single oral administration, showing low but measurable . A Phase 2/3 trial (COVA) in 2024 for severe demonstrated that oral BIO101 at 12 mg/kg/day reduced the risk of death or by 43.8% (primary endpoint) compared to , highlighting efficacy in acute respiratory conditions relevant to COPD. For , preclinical studies in gerbil models and early human data from 2020s trials indicate benefits at similar doses, including improved lipid profiles and insulin sensitivity without adverse events. Formulations such as complexes have been developed to enhance and , addressing limitations in pharmaceutical . Key challenges in 20E include its poor oral , estimated at approximately 10-12% in and gerbil models due to rapid and low (0.084 mg/mL in ), necessitating high doses or improved delivery systems. Efforts to develop analogs for enhanced potency are ongoing, though recent patents focus more on extraction and purification methods from plant sources like Cyanotis arachnoidea rather than synthetic derivatives. Recent advances from 2024-2025 include preclinical targeting of (ALS) through modulation for , with human data pending; in January 2025, Biophytis entered a co-development with AskHelpU to assess BIO101's in in , and cardioprotective effects in ischemia/ models, partially alleviating damage post-tourniquet application in mice. Patents on pharmaceutical-grade 20E extracts and RAAS-modulating formulations have supported progression, with Biophytis securing U.S. patents extending to 2039. Regulatory progress includes () approval from the FDA in July 2024 for a Phase II trial (OBA) in , and European Medicines Agency designation in 2018 for DMD treatment.

References

  1. [1]
    20-Hydroxyecdysone | C27H44O7 | CID 5459840 - PubChem
    20-Hydroxyecdysone is an ecdysteroid that is ecdysone substituted by a hydroxy group at position 20. It has a role as a plant metabolite and an animal ...
  2. [2]
    20-Hydroxyecdysone, from Plant Extracts to Clinical Use
    There is growing interest in the pharmaceutical and medical applications of 20-hydroxyecdysone (20E), a polyhydroxylated steroid which naturally occurs in low ...
  3. [3]
    The phytochemical, biological, and medicinal attributes of ...
    Figure 1. Structures of 20-hydroxyecdysone (1), ponasterones A (2), B (3) and C (4). Chemically, ecdysteroids are polar steroids in nature; their solubility is ...
  4. [4]
    20-Hydroxyecdysone: Uses, Interactions, Mechanism of Action
    Sep 13, 2022 · Structure for 20-Hydroxyecdysone (DB16935) · 20-hydroxy-.alpha.-ecdysone · Cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2.beta.,3.beta.,5.
  5. [5]
    Ecdysterone | C27H44O7 - ChemSpider
    [IUPAC name – generated by ACD/Name]. (2β,3β,5β,22R)-2,3,14,20,22,25-Hexahydroxycholest-7-én-6-one. [French]. [IUPAC name – generated by ACD/Name]. 20-hydroxy ...
  6. [6]
    Ecdysone | C27H44O6 | CID 19212 - PubChem - NIH
    Ecdysone is a 6-oxo steroid that is 5beta-cholest-7-en-6-one substituted by hydroxy groups at positions 2, 3, 14, 22 and 25 respectively.
  7. [7]
    Enzo Life Sciences 20-Hydroxyecdysone (50mg). CAS: 5289-74-7
    4–8 day delivery 30-day returnsPurity: ≥95% HPLC. Appearance: White powder. Solubility: Soluble in water, 100% ethanol, methanol, DMSO and acetic acid. Long Term Storage: -20°C ...Missing: physical stability spectroscopic
  8. [8]
  9. [9]
    Showing NP-Card for 20-hydroxyecdysone (NP0024638) - NP-MRD
    Jun 19, 2021 · Water Solubility, 353.1 mg/L @ 25 °C (est), The Good Scents Company Information System. LogP, -0.270 (est), The Good Scents Company Information ...
  10. [10]
    [PDF] PRODUCT INFORMATION - Cayman Chemical
    The solubility of 20-hydroxy ecdysone in ethanol is approximately 25 mg/ml and approximately 30 mg/ml in. DMSO and DMF. Further dilutions of the stock solution ...Missing: properties spectroscopic<|control11|><|separator|>
  11. [11]
    20-Hydroxyecdysone, from Plant Extracts to Clinical Use - MDPI
    The aim of this review is to describe the potential and challenges in developing 20-hydroxyecdysone (20E) as a pharmaceutical agent for the future.
  12. [12]
    Neverland is an evolutionally conserved Rieske-domain protein that ...
    We describe the neverland (nvd) gene ... Furthermore, the phenotype is rescued by application of 20-hydroxyecdysone or the precursor 7-dehydrocholesterol.
  13. [13]
    Neverland is an evolutionally conserved Rieske-domain protein that ...
    Jul 1, 2006 · Developmental progression of nvd-Dm RNAi animals by feeding 20-hydroxyecdysone, cholesterol and 7-dehydrocholesterol.nvd-DmRNAi (black ...
  14. [14]
    Sterol Regulation of Development and 20-Hydroxyecdysone ... - MDPI
    In the specialized ecdysteroidogenic organ that called the prothoracic glands, cholesterol is firstly converted into 7-dehydrocholesterol (7-dhC) by Neverland ( ...<|separator|>
  15. [15]
    Halloween genes in panarthropods and the evolution of ... - PubMed
    Sep 12, 2018 · Their biosynthesis is regulated by the Rieske-domain protein Neverland and cytochrome P450 enzymes encoded by the so-called 'Halloween' genes.
  16. [16]
    The Halloween genes code for cytochrome P450 enzymes ...
    Oct 25, 2006 · The final four sequential hydroxylations of steroid precursors into the active ecdysteroid of insects, 20E (20-hydroxyecdysone), are mediated by ...
  17. [17]
    Shade is the Drosophila P450 enzyme that mediates the ... - PubMed
    The steroid 20-hydroxyecdysone (20E) is the primary regulatory hormone that mediates developmental transitions in insects and other arthropods.Missing: biosynthesis | Show results with:biosynthesis<|control11|><|separator|>
  18. [18]
    Identification and Evolution Analysis of the Genes Involved in the 20 ...
    Dec 10, 2024 · The synthesis pathway of 20-hydroxyecdysone (20E) in arthropods is a complex multi-step biosynthetic process that begins with cholesterol and ...
  19. [19]
    Biosynthesis of ecdysteroid hormones by crustacean Y-organs
    A pair of glands (Y-organs) in crustaceans synthesize and secrete ecdysteroid hormones; the obligate precursor for synthesis is circulating cholesterol.
  20. [20]
    Signaling Pathways That Regulate the Crustacean Molting Gland
    A pair of Y-organs (YOs) are the molting glands of decapod crustaceans. They synthesize and secrete steroid molting hormones (ecdysteroids)
  21. [21]
    Involvement of cyclic AMP-dependent protein kinase in ... - PubMed
    Prothoracicotropic hormone (PTTH) is a brain neuropeptide that stimulates the prothoracic glands to synthesize ecdysone, an event that leads to insect ...
  22. [22]
    Ecdysone-dependent feedback regulation of prothoracicotropic ...
    We find that ecdysone-mediated feedback via EcR in the PTTHn drives the pupariation-triggering PTTH surge, thereby determining the timing of maturation. Under ...
  23. [23]
    Ecdysteroid Biosynthesis in Crayfish Y-organs: Feedback ... - PubMed
    In crustaceans, ecdysteroid synthesis in the Y-organs is negatively regulated by the molt-inhibiting hormone (MIH). Reduction or cessation of MIH release ...
  24. [24]
    Neurohormonal control of ecdysone production
    Ecdysteroid synthesis is regulated in insects by prothoracicotropic hormone (PTTH) and in crustaceans by molt-inhibiting hormone (MIH).
  25. [25]
    A molecular genetic approach to the biosynthesis of the insect ...
    Insect growth, development, and molting depend upon a critical titer of the principal molting hormone of arthropods, 20-hydroxyecdysone (20E).
  26. [26]
    Ecdysteroids: production in plant in vitro cultures
    Nov 24, 2016 · Ecdysteroids are also present in several conifers and a vast number of angiosperm species belonging to families Caryophyllaceae, Amaranthaceae, ...
  27. [27]
    Phytoecdysteroids: Distribution, Structural Diversity, Biosynthesis ...
    Aug 4, 2022 · These compounds contribute to mitigating biotic and abiotic stresses. In plants, PEs play a potent role in enhancing tolerance against insects ...
  28. [28]
    Efficient extraction and sensitive HPLC-MS/MS quantification of ...
    This study aimed to develop a new analytical approach for the simultaneous determination of four ecdysones (muristerone A, makisterone A, 20E, and ponasterone A) ...
  29. [29]
    Highly Oxidized Ecdysteroids from a Commercial Cyanotis ...
    Feb 24, 2023 · The compounds tested demonstrated a significant protective effect on the blood–brain barrier endothelial cells against oxidative stress or inflammation.
  30. [30]
    Phytoecdysteroids as antifeedants towards several beetles that ...
    Dec 15, 2016 · Plants are thought to produce ecdysteroids as a means of protection from insect herbivores. Some insects will not feed on plants containing high ...
  31. [31]
    Fluctuation of 20-hydroxyecdysone in individual organs of ...
    Jun 30, 2013 · Concentrations of 20E in root and floral part were much higher than those in stem and leaf during reproductive growth stage and rapidly ...
  32. [32]
    NaCl induced salt adaptive changes and enhanced accumulation of ...
    Aug 29, 2019 · The higher synthesis 20-hydroxyecdysone in Spinach shoot cultures might be linked with the prevention of membrane damage induced by salinity ...
  33. [33]
    Biotransformations of 20-hydroxyecdysone and analogues by ...
    20-Hydroxyecdysone, the arthropod moulting hormone, was biotransformed by the fungus Curvularia lunata NRRL 2178 to the rare ecdysteroid, ...<|separator|>
  34. [34]
    Detection and identification of 20-hydroxyecdysone metabolites in ...
    The major 20E metabolite was 14-deoxy-20-hydroxyecdysone, which was detected in samples four to five hours after oral administration, whereas 20E was still ...<|control11|><|separator|>
  35. [35]
    The Distribution of Phytoecdysteroids among Terrestrial Vascular ...
    Feb 9, 2023 · Phytoecdysteroids are a class of plant secondary compounds which are present in a wide diversity of vascular plant species, ...
  36. [36]
    Ecdysone Control of Developmental Transitions: Lessons from ...
    20E is the primary molting hormone that binds to a nuclear receptor and initiates various gene expression cascades, which ultimately lead to the physiological, ...
  37. [37]
    Ecdysone Receptor Agonism Leading to Lethal Molting Disruption in ...
    Over half a century research on arthropod endocrinology reveals that molting is precisely controlled by a complex multi-hormone system, with 20-hydroxyecdysone ...
  38. [38]
    Discrete Pulses of Molting Hormone, 20-Hydroxyecdysone, During ...
    Periodic pulses of the insect steroid molting hormone 20-hydroxyecdysone (20E), acting via its nuclear receptor complex (EcR/USP), control gene expression.
  39. [39]
    Review Crustacean ecdysteriods in reproduction and embryogenesis
    In crustaceans, ecdysteroids are synthesized by the ecdysial glands, called Y-organs. It is generally known that the Y-organs secrete ecdysone, which on ...
  40. [40]
    The Effects of Exogenous 20-Hydroxyecdysone on the Feeding ...
    Thus, ingestion of exogenous 20E exerted adverse effects on feeding, development, and reproduction of P. xylostella, and 20E residues on leaves of host plant ...Missing: functions | Show results with:functions
  41. [41]
    Effect of 20-Hydroxyecdysone, a Phytoecdysteroid, on Development ...
    Oct 22, 2019 · The obtained results in this study revealed that the mortality increased significantly after ingestion of 20-hydroxyecdysone in a dose-dependent ...
  42. [42]
    Concentration-Dependent Feeding Deterrence to 20 ... - MDPI
    The purpose of this study was to determine what concentrations of 20E, if any, cause termite workers to feed less readily. To test this, paper disks were ...Missing: functions | Show results with:functions
  43. [43]
    Phytoecdysteroids: Distribution, Structural Diversity, Biosynthesis ...
    In plants, PEs play a potent role in enhancing tolerance against insects and nematodes via their allelochemical activity, which increases plant biological and ...
  44. [44]
    A Novel Defense Against Plant-Parasitic Nematodes
    The phytoecdysteroid, 20-hydroxyecdysone (20E), is a major molting hormone of invertebrates possibly including nematodes. As 20E is inducible in spinach, ...
  45. [45]
    Role of Phytoecdysteroids in Insect Pest Management: A Review
    Jan 10, 2018 · These phytoecdysteroids provide little protection against specialized herbivores, which have evolved efficient detoxification mechanisms but ...
  46. [46]
    Phytoecdysteroids: a novel defense against plant-parasitic nematodes
    The phytoecdysteroid, 20-hydroxyecdysone (20E), is a major molting hormone of invertebrates, possibly including nematodes. As 20E is inducible in spinach, ...Missing: annelids | Show results with:annelids<|control11|><|separator|>
  47. [47]
    Full article: Ecdysteroids in helminths and annelids
    Feb 25, 2011 · This review focuses on recent research developments in the past three years concerning ecdysteroid biochemistry in helminths and annelids, ...
  48. [48]
    [PDF] 20-Hydroxyecdysone - Bertin Corp
    Reconstitute the 20-hydroxyecdysone Standard vial #A06120 with 1 mL of UltraPure water. Allow it to stand 5 minutes until completely dissolved and then mix ...Missing: solubility | Show results with:solubility
  49. [49]
    20-Hydroxyecdysone protects wheat seedlings (Triticum aestivum L ...
    Dec 8, 2015 · Our results show that 20E protects oxidative balance and enhances the anti-oxidative systems, and more specifically the ascorbate-glutathione ...
  50. [50]
  51. [51]
  52. [52]
  53. [53]
  54. [54]
  55. [55]
  56. [56]
  57. [57]
  58. [58]
    Ecdysteroid signalling in insects—From biosynthesis to gene ...
    In 1954, the first “moulting hormone” was isolated and named ecdysone (Butenandt and Karlson, 1954), followed by identification of the second hormone, 20- ...
  59. [59]
    Mode of Action of Ecdysones - SpringerLink
    When we coined the term, “ecdysone”, we believed that only one substance would exist naturally, the one isolated by us from Bombyx pupae (Butenandt and Karlson, ...
  60. [60]
    Shade is the Drosophila P450 enzyme that mediates the ... - PNAS
    The steroid 20-hydroxyecdysone (20E) is the primary regulatory hormone that mediates developmental transitions in insects and other arthropods.
  61. [61]
    Chemical Treatments for Insect Cell Differentiation: The Effects of 20 ...
    Dec 28, 2021 · The active metabolite of ecdysone is 20-hydroxyecdysone (20-HE), and many insect species use it as a regulator of molting and other processes, ...<|control11|><|separator|>
  62. [62]
    Developmental studies on two ecdysone deficient mutants ...
    Thegrg mutant larvae, on the other hand, fail to pupate after 20-hydroxyecdysone feeding as well as injection. The primary defect of thegrg mutant is not ...
  63. [63]
    Estrogen receptor beta is involved in skeletal muscle hypertrophy ...
    Jun 27, 2014 · Estrogen receptor beta is involved ... 7Kuzmenko, A. I., Niki, E., Noguchi, N., New functions of 20-hydroxyecdysone in lipid peroxidation.
  64. [64]
    Genome‐wide CRISPR screening reveals key genes and pathways ...
    Jun 27, 2023 · Genome-wide CRISPR screening reveals key genes and pathways associated with 20-hydroxyecdysone signal transduction in the silkworm (Bombyx mori).
  65. [65]
    EcR agonism leading to mortality via suppression of Ftz-f1 - AOP-Wiki
    Oct 2, 2025 · ... tools used). More help. The AOP was developed based on structured ... insect molting disruption, 20-hydroxyecdysone, and ecdysteroid signaling.
  66. [66]
    Ecdysterone and Turkesterone—Compounds with Prominent ... - MDPI
    The current review investigates the beneficial biological effects of ecdysterone and turkesterone in nutrition, highlighting their roles not only in enhancing ...
  67. [67]
    What Athletes Need to Know about Ecdysteroids - USADA
    However, there is some recent evidence that ecdysteroids may interact with some estrogen receptors in the body, and that consuming ecdysteroids in supplements ...Missing: studies | Show results with:studies
  68. [68]
    [PDF] THE 2020 MONITORING PROGRAM* - WADA
    *The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program.
  69. [69]
  70. [70]
  71. [71]
    [PDF] wg-compendium-of-botanicals.pdf - EFSA
    The first issue concerns the use of ecdysteroids and more specifically ecdysterone in food supplements for anabolic purposes. ... and rate the literature ...Missing: restrictions | Show results with:restrictions
  72. [72]
  73. [73]
    Ecdysterone Supplement Charting Growth Trajectories: Analysis ...
    Rating 4.8 (1,980) Jun 17, 2025 · The size of the Ecdysterone Supplement market was valued at USD 381 million in 2024 and is projected to reach USD 619.85 million by 2033, with ...
  74. [74]
    Ecdysteroid-containing food supplements from Cyanotis ... - Nature
    Dec 8, 2016 · Phytoecdysteroids like 20-hydroxyecdysone (“ecdysterone”) can exert a mild, non-hormonal anabolic/adaptogenic activity in mammals, and as ...
  75. [75]
    20-Hydroxyecdysone, from Plant Extracts to Clinical Use - PubMed
    Apr 29, 2021 · 20-hydroxyecdysone (20E), a polyhydroxylated steroid which naturally occurs in low but very significant amounts in invertebrates, where it has hormonal roles.Missing: allelopathic | Show results with:allelopathic
  76. [76]
    A Phase 1 study for safety and pharmacokinetics of BIO101 (20 ...
    Apr 13, 2023 · BIO101 is a 20E purified investigational drug (≥97%) that previously demonstrated good toxicology profiles in rat and dog.
  77. [77]
    Evaluating the effect of 20-hydroxyecdysone (20HE) on mechanistic ...
    Evaluating the effect of 20-hydroxyecdysone (20HE) on mechanistic target of rapamycin complex 1 (mTORC1) signaling in the skeletal muscle and liver of rats.Missing: Duchenne dystrophy
  78. [78]
    Combined 20-Hydroxyecdysone and Antisense-Mediated Exon ...
    Feb 17, 2025 · In this study, we evaluated the combination of tricyclo-DNA-ASO targeting the Dmd exon 23 with 20-hydroxyecdysone (20-E), a steroid hormone ...Missing: mTOR | Show results with:mTOR
  79. [79]
    20-Hydroxyecdysone ameliorates metabolic and cardiovascular ...
    May 6, 2020 · 20-Hydroxyecdysone increases fiber size in a muscle-specific fashion in rat. ... Estrogen receptor beta is involved in skeletal muscle hypertrophy ...
  80. [80]
    Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor ...
    Jan 2, 2024 · The aim of the study was to test whether Mas-receptor activation by 20-hydroxyecdysone (BIO101) could restore the Renin-Angiotensin System ...
  81. [81]
    20-Hydroxyecdysone bioavailability and pharmacokinetics in ...
    The calculated oral bioavailability of 20E is approx. 12%, with a half-life of 30.6 and 33 min after per os administration or intra-peritoneal injection, ...Missing: absorption | Show results with:absorption
  82. [82]
    [PDF] 20-Hydroxyecdysone's Cyclodextrin Complex: A Novel Anabolic ...
    However, 20-HE is molecularly a steroid, thus having relatively poor water solubility and poor human oral bioavailability. Cyclodextrins (CDs) are being used in ...
  83. [83]
    A Commercial Extract of Cyanotis arachnoidea Roots as a Source of ...
    Jun 18, 2021 · Phytoecdysteroids like 20-hydroxyecdysone ("ecdysterone") can exert a mild, non-hormonal anabolic/adaptogenic activity in mammals, and as such, ...
  84. [84]
    20-Hydroxyecdysone Partially Alleviates Ischemia/Reperfusion ...
    Aug 7, 2025 · Duchenne muscular dystrophy is caused by loss of the dystrophin protein. This pathology is accompanied by mitochondrial dysfunction contributing ...
  85. [85]
    [PDF] Dietary Phytoecdysteroids - Biophytis
    Hydroxyl groups may be located at various positions around the molecule and vary in their ... 20E 20-hydroxyecdysone, HF high-fat diet, LF low-fat diet, Q quinoa.
  86. [86]
    EU/3/18/2030 - orphan designation for treatment of Duchenne ... - EMA
    Aug 21, 2018 · On 27 June 2018, orphan designation (EU/3/18/2030) was granted by the European Commission to Biophytis, France, for 20-hydroxyecdysone for treatment of ...<|control11|><|separator|>